QQQ   426.41 (-1.09%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.41 (-1.09%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.41 (-1.09%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.41 (-1.09%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Enlivex Therapeutics (ENLV) Short Interest Ratio & Short Volume

$1.45
0.00 (0.00%)
(As of 12:25 PM ET)

Enlivex Therapeutics Short Interest Data

Current Short Volume
236,400 shares
Previous Short Volume
261,500 shares
Change Vs. Previous Month
-9.60%
Dollar Volume Sold Short
$895,956.00
Short Interest Ratio / Days to Cover
2.7
Last Record Date
March 31, 2024
Outstanding Shares
18,570,000 shares
Percentage of Shares Shorted
1.27%
Today's Trading Volume
320,708 shares
Average Trading Volume
166,897 shares
Today's Volume Vs. Average
192%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Enlivex Therapeutics ?

Sign up to receive the latest short interest report for Enlivex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENLV Short Interest Over Time

ENLV Days to Cover Over Time

ENLV Percentage of Float Shorted Over Time

Enlivex Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024236,400 shares $895,956.00 -9.6%N/A2.7 $3.79
3/15/2024261,500 shares $1.07 million +15.4%N/A2.4 $4.11
2/29/2024226,600 shares $703,593.00 +51.2%N/A2.2 $3.11
2/15/2024149,900 shares $481,179.00 -6.6%N/A1.6 $3.21
1/31/2024160,500 shares $449,400.00 -13.7%N/A1.9 $2.80
1/15/2024185,900 shares $533,533.00 +32.5%N/A2.3 $2.87
12/31/2023140,300 shares $378,810.00 +36.0%N/A1.8 $2.70
12/15/2023103,200 shares $145,512.00 -6.3%N/A1.9 $1.41
11/30/2023110,100 shares $202,584.00 -0.9%N/A3.5 $1.84
11/15/2023111,100 shares $194,425.00 -6.2%N/A3.6 $1.75
10/31/2023118,400 shares $157,472.00 +13.1%N/A3.9 $1.33
10/15/2023104,700 shares $147,627.00 -8.1%N/A4.1 $1.41
9/30/2023113,900 shares $179,962.00 +4.4%N/A4.5 $1.58
9/15/2023109,100 shares $206,199.00 +3.4%N/A4.2 $1.89
8/31/2023105,500 shares $252,145.00 -9.3%N/A4.8 $2.39
8/15/2023116,300 shares $303,543.00 +2.4%N/A5.1 $2.61
7/31/2023113,600 shares $290,816.00 +8.6%N/A4.9 $2.56
7/15/2023104,600 shares $248,948.00 +2.5%N/A4.8 $2.38
6/30/2023102,100 shares $268,247.33 -20.2%N/A3.6 $2.63
6/15/2023128,000 shares $362,240.00 +5.6%N/A3.6 $2.83
5/31/2023121,200 shares $316,332.00 -5.8%N/A3.5 $2.61
5/15/2023128,700 shares $359,073.00 -1.2%N/A3.8 $2.79
4/30/2023130,200 shares $369,768.00 -4.6%N/A3.7 $2.84
4/15/2023136,400 shares $396,924.00 -15.7%N/A3.6 $2.91
3/31/2023161,700 shares $588,588.00 +0.5%N/A4.3 $3.64
3/15/2023160,900 shares $577,631.00 -1.3%N/A5.9 $3.59
2/28/2023163,000 shares $652,000.00 +0.9%N/A5.7 $4.00
2/15/2023161,500 shares $673,455.00 -8.8%N/A5.5 $4.17
1/31/2023177,100 shares $775,698.00 -2.9%N/A5.8 $4.38
1/15/2023182,300 shares $796,505.16 -4.8%N/A6.9 $4.37
12/30/2022191,400 shares $753,637.50 -0.5%N/A7.8 $3.94
12/15/2022192,400 shares $779,220.00 -11.5%N/A9.2 $4.05
11/30/2022217,500 shares $996,998.25 +16.9%N/A9 $4.58
11/15/2022186,000 shares $894,660.00 +0.1%N/A6.9 $4.81
10/31/2022185,800 shares $797,082.00 -3.8%N/A6.6 $4.29
10/15/2022193,100 shares $805,227.00 +1.2%N/A5.4 $4.17
9/30/2022190,900 shares $811,325.00 +4.5%N/A4.4 $4.25
9/15/2022182,700 shares $959,175.00 -5.4%N/A3.9 $5.25
8/31/2022193,100 shares $1.01 million -7.0%N/A4.2 $5.25
8/15/2022207,700 shares $1.08 million -9.5%N/A4.4 $5.22
Warning: Biden’s revenge against Trump voters? (Ad)

Is THIS Joe Biden’s planned revenge against Trump? Bumbling Biden will lose in November.

But a former CIA advisor now holds evidence…

ENLV Short Interest - Frequently Asked Questions

What is Enlivex Therapeutics' current short interest?

Short interest is the volume of Enlivex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 236,400 shares of ENLV short. Learn More on Enlivex Therapeutics' current short interest.

What is a good short interest ratio for Enlivex Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENLV shares currently have a short interest ratio of 3.0. Learn More on Enlivex Therapeutics's short interest ratio.

Which institutional investors are shorting Enlivex Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Enlivex Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Enlivex Therapeutics' short interest increasing or decreasing?

Enlivex Therapeutics saw a decrease in short interest in March. As of March 31st, there was short interest totaling 236,400 shares, a decrease of 9.6% from the previous total of 261,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Enlivex Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Enlivex Therapeutics: Aptorum Group Limited (3.91%), Forte Biosciences, Inc. (0.09%), Sol-Gel Technologies Ltd. (0.12%), Eyenovia, Inc. (11.01%), Acurx Pharmaceuticals, Inc. (2.83%), Aileron Therapeutics, Inc. (0.88%), Viracta Therapeutics, Inc. (2.37%), Unity Biotechnology, Inc. (2.00%), Spruce Biosciences, Inc. (1.46%), Sensei Biotherapeutics, Inc. (0.96%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Enlivex Therapeutics stock?

Short selling ENLV is an investing strategy that aims to generate trading profit from Enlivex Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enlivex Therapeutics?

A short squeeze for Enlivex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENLV, which in turn drives the price of the stock up even further.

How often is Enlivex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENLV, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ENLV) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners